Iseganan hydrochloride: Phase IIa

In a double-blind, placebo-controlled U.S. Phase IIa trial in 16 mechanically ventilated patients, treatment with Iseganan was well tolerated and reduced the mean numbers of oral microorganisms by 1 l...